Home›People›Richard Minicus
Richard Minicus

Richard Minicus

Chief financial officer, GRIP Molecular Technologies

Executive
Updated Nov 6, 2026·Latest SEC filing Oct 29, 2026·Suggest an edit

About Richard Minicus

Richard Minicus is chief financial officer of GRIP Molecular Technologies. He has more than 30 years of experience in mergers and acquisitions, venture capital and capital markets. He holds an MBA from Harvard Business School and a master's degree in biology from Fairleigh Dickinson University.

Earlier, he spent 21 years in medical technology business development at Becton Dickinson and Pfizer. He also spent nine years in commercial and investment banking at Merrill Lynch Capital Markets and JP Morgan. He made investments in young medical technology and life science companies through BD Ventures and Merrill Lynch Venture Capital.

Experience

This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Richard Minicus in the role, so the role may have started earlier or lasted longer.

GRIP Molecular Technologies Inc. Current
CFO
2022 – Present · Saint Paul, MN
A CRISPR protease test platform that detects pathogen RNA in minutes and works with several readout formats.
Becton Dickinson
Pfizer
Merrill Lynch Capital Markets
JP Morgan

Key Colleagues at Startups

The people Richard Minicus works with at each company, as listed on that company's latest Form D.

GRIP Molecular Technologies Inc. · Form D/A, Oct 29, 2026
Bruce Batten
Bruce Batten
Founder | CSO
Edward Ludwig
Edward Ludwig
Board Chairman
Edward Gillen
Edward Gillen
CEO | CCO

Sources

  1. SECGRIP Molecular Technologies Inc. Form D/A, filed Oct 29, 2026